/PRNewswire/ The cell sorting market is expected to grow by USD 129.02 million from 2022 to 2027. In addition, the momentum of the market will progress at a.
SAN JOSE, Calif. (PRWEB) February 22, 2023 Molecular Devices, LLC., a leading provider of high-performance life science solutions, is demonstrating its
Molecular Devices, LLC. , a leading provider of high-performance life science solutions, has announced the acquisition of Cellesce Ltd (“Cellesce”) which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening.